The Watchful Many: Platelets at the Intersection of Hemostasis, Immunity, and Cancer

Platelets are anucleate megakaryocyte-derived cytoplastic fragments best known for their roles in hemostasis and thrombosis, but they also play roles in systemic immune surveillance, vascular integrity, and tissue homeostasis. In cancer, this versatility is co-opted through communication between the tumor, bone marrow, and platelets. Tumor-derived cytokines, extracellular vesicles, and inflammatory cues can rewire thrombopoiesis and platelet activation, lifespan, and cargo, giving rise to tumor-educated platelets. Platelets support multiple stages of cancer progression by promoting metastatic traits in the tumor, cancer cell survival in the circulation, immune evasion, and vascular adhesion. Clinically, platelets are key drivers of coagulopathies in cancer patients, including venous and arterial thromboembolism, thrombotic microangiopathy, and disseminated intravascular coagulation. Here, we review platelet biology at the intersection of hemostasis, inflammation, and cancer.

Authors

Institutions

Publication Details

Journal
Annual Review of Cancer Biology
Published
2026-11-13
DOI
https://doi.org/10.1146/annurev-cancerbio-061225-082730
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Watchful Many: Platelets at the Intersection of Hemostasis, Immunity, and Cancer

José M. Adrover, Jack Leslie, Afshan McCarthy, Erik Ramon‐Gil et al.
1 links
Annual Review of Cancer Biology
Platelet Disorders and Treatments
article

The Watchful Many: Platelets at the Intersection of Hemostasis, Immunity, and Cancer

José M. Adrover, Jack Leslie, Afshan McCarthy, Erik Ramon‐Gil, Lucia Dominguez-Esteban
article en

Abstract

Platelets are anucleate megakaryocyte-derived cytoplastic fragments best known for their roles in hemostasis and thrombosis, but they also play roles in systemic immune surveillance, vascular integrity, and tissue homeostasis. In cancer, this versatility is co-opted through communication between the tumor, bone marrow, and platelets. Tumor-derived cytokines, extracellular vesicles, and inflammatory cues can rewire thrombopoiesis and platelet activation, lifespan, and cargo, giving rise to tumor-educated platelets. Platelets support multiple stages of cancer progression by promoting metastatic traits in the tumor, cancer cell survival in the circulation, immune evasion, and vascular adhesion. Clinically, platelets are key drivers of coagulopathies in cancer patients, including venous and arterial thromboembolism, thrombotic microangiopathy, and disseminated intravascular coagulation. Here, we review platelet biology at the intersection of hemostasis, inflammation, and cancer.

Annual Review of Cancer Biology
The Francis Crick Institute (GB), Newcastle University (GB)
Good health and well-being
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon